QUOTE AND NEWS
Forbes  Jan 24  Comment 
Looking at the sectors faring worst as of midday Tuesday, shares of Healthcare companies are underperforming other sectors, showing a 0.3% loss. Within the sector, Endo International plc (NASD: ENDP) and Waters Corp. (NYSE: WAT) are two large...
newratings.com  Jan 24  Comment 
WASHINGTON (dpa-AFX) - Waters Corp. (WAT) reported earnings for its fourth quarter that rose compared to the same period last year. The company said its bottom line advanced to $179.01 million, or $2.21 per share. This was up from $161.22...
Forbes  Jan 13  Comment 
In afternoon trading on Friday, Healthcare stocks are the best performing sector, higher by 0.5%. Within that group, Waters Corp. (NYSE: WAT) and Patterson Companies Inc (NASD: PDCO) are two of the day's stand-outs, showing a gain of 2.7% and...
newratings.com  Dec 8  Comment 
WASHINGTON (dpa-AFX) - Waters Corp. (WAT) announced Sherry Buck as its Senior Vice President and CFO, effective January 9, 2017. Ms. Buck replaces Eugene Cassis, Waters' CFO, who will transition to a senior advisory role. Ms. Buck has been...
Motley Fool  Oct 25  Comment 
Shares of the scientific-instrument manufacturer sank after an earnings report that forecast rocky waters ahead.




 
TOP CONTRIBUTORS


The Waters Corporation develops analytical instruments for use in the pharmaceutical, life science, biochemical, industrial, academic, and government industries. It develops primarily high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC®” and together with HPLC, referred to as “LC”), mass spectrometry (“MS”), thermal analysis, rheometry and calorimetry instruments. The company markets its instruments in the United States, Europe, and Asia. Due to the large capital expenditure of its instruments Water's revenues experience seasonality and can fluctuate according to capital spending patterns of customers, tending to be larger in the fourth quarter of each year.[1]

Business Growth

For 2010 the company reported product sales of $1,167 million and service sales of $477 million dollars; an increase from 2009 of 11% and 7%, respectively. The increase in product sales was due primarily to improved demand by customers as a result of improved economic conditions and an increase in sales from its newly introduced UPLC H-Class, SYNAPT G-2 and Xevo Q-Tof instrument systems. Service sales were up due to increased sales of service plans and billings because of a higher installed base of customers.[1]

Trends and Forces

Water's revenues can fluctuate according to capital spending patterns of customers

WAT's customers often stock up on lab consumables and equipment at the end of the year, when funding is abundant (for example, NIH funding is distributed to labs towards the end of the calendar year). WAT's revenues thus fluctuate throughout the year and are strongest in the last quarter of the calendar year. NIH funding is not completely stable, either - economic pressures may result in a stagnation of NIH funding, which has been growing at 2-3% in the past few years, but is not expected to increase in the near future. WAT's customers from academic and government research labs are directly affected by the limitations of NIH grant funding; a lack of funding results in fewer laboratory product and equipment purchases and adversely affects WAT's sales revenues.[1]

Competition

The company competes globally primarily on the basis of instrument performance, reliability, service and, to a lesser extent, price. Some of these competitors include[1]:

References

  1. 1.0 1.1 1.2 1.3 Waters Corporation 2011 10k
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki